Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Kosan Biosciences Inc | 45 |
| 2 | Pfizer Inc | 33 |
| 3 | Pfizer Corp SRL | 25 |
| 4 | Abbott Laboratories | 24 |
| 5 | Fidelta doo | 21 |
| 6 | Melinta Subsidiary Corp | 15 |
| 7 | Beecham Group PLC | 12 |
| 8 | Pfizer Corp Belgium | 12 |
| 9 | Merck Sharp & Dohme LLC | 11 |
| 10 | Leland Stanford Junior University | 10 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C07H | Sugars and derivatives | 236 |
| 2 | A61P | Therapeutic activity (drug indications) | 214 |
| 3 | A61K | Medicinal preparations | 97 |
| 4 | C12N | Microorganisms, enzymes | 85 |
| 5 | C07D | Heterocyclic compounds | 81 |
| 6 | C12P | Fermentation, enzyme processes | 77 |
| 7 | C07K | Peptides | 23 |
| 8 | Y02P | Climate change mitigation: production | 23 |
| 9 | C40B | 14 | |
| 10 | Y02A | Climate change adaptation | 11 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Hung‐wen Liu | The University of Texas at Austin | 10 |
| 2 | Lishan Zhao | University of Minnesota | 4 |
| 3 | Clelia Peano | National Research Council | 3 |
| 4 | David H. Sherman | University of Michigan–Ann Arbor | 3 |
| 5 | E. Sethe Burgie | University of Wisconsin–Madison | 3 |
| 6 | Gianluca De Bellis | National Research Council | 3 |
| 7 | Giorgio Corti | National Research Council | 3 |
| 8 | Hazel M. Holden | University of Wisconsin–Madison | 3 |
| 9 | Mark W. Ruszczycky | The University of Texas at Austin | 3 |
| 10 | Shengying Li | University of Michigan–Ann Arbor | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| The Structural Basis for Substrate Anchoring, Active Site Selectivity, and Product Formation by P450 PikC from Streptomyces venezuelae | 2006 | 147 | Microbial Natural Products and Biosynthesis |
| Photodegradation of azithromycin in various aqueous systems under simulated and natural solar radiation: Kinetics and identification of photoproducts | 2011 | 124 | Pharmaceutical and Antibiotic Environmental Impacts |
| Construction of desosamine containing polyketide libraries using a glycosyltransferase with broad substrate specificity | 2001 | 86 | Microbial Natural Products and Biosynthesis |
| Stereoselective Synthesis of | 2004 | 73 | Carbohydrate Chemistry and Synthesis |
| Macrolide Therapy in Chronic Inflammatory Diseases | 2012 | 70 | Pneumonia and Respiratory Infections |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of this compound?
Which organizations hold the most patents related to this compound?
What are the main patent classification areas for this compound?
Who are the leading academic researchers publishing on this compound?
What research topics are most associated with this compound in the literature?